Tag: Objective

ROUGEMONT, Québec, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Lassonde Industries Inc. (TSX: LAS.A) (“Lassonde” or the “Corporation”) today announced its financial results for the second quarter of 2025.

MONTRÉAL, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Saputo Inc. (TSX: SAP) (we, Saputo or the Company) reported today its financial results for the first quarter of fiscal 2026, which ended on June 30, 2025. All amounts in this news release are in millions of Canadian dollars (CDN), except per share amounts, unless otherwise indicated, and are presented according to International Financial Reporting Standards (IFRS).

TORONTO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Timbercreek Financial Corp. (TSX: TF) ("Timbercreek Financial" or the "Company") is pleased to announce a significant update to its credit facilities. On August 7, 2025, Timbercreek Financial entered into a second amending agreement to the third amended and restated credit agreement (the "New Credit Agreement") with a syndicate of nine lenders. The New Credit Agreement provides for revolving credit facilities totaling $600 million, including a $20 million swingline facility, up from the previous $510 million credit facility. The facility also includes a $100 million accordion feature for future expansion, subject to certain conditions. The term of the New Credit Agreement is two years, maturing on August 7, 2027. The Toronto-Dominion Bank will continue to act as sole lead arranger, sole book-runner, and administration agent.

MONTRÉAL, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Saputo Inc. (TSX: SAP) (we, Saputo or the Company) reported today its financial results for the first quarter of fiscal 2026, which ended on June 30, 2025. All amounts in this news release are in millions of Canadian dollars (CDN), except per share amounts, unless otherwise indicated, and are presented according to International Financial Reporting Standards (IFRS).

Company Details Plans to Increase Production, Cash Flows in Q4 2025

FLORHAM PARK, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced that the Company will report financial results for the second quarter ended June 30, 2025, and provide a corporate update on August 14, 2025, at 8:30 a.m. Eastern Time.

VANCOUVER, British Columbia, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Diversified Royalty Corp. (TSX: DIV and DIV.DB.A) (the “Corporation” or “DIV”) is pleased to announce its financial results for three months ended June 30, 2025 (“Q2 2025”) and six months ended June 30, 2025.